Cargando…
Industry sponsorship bias in cost effectiveness analysis: registry based analysis
OBJECTIVE: To assess the association between industry sponsorship (drug, medical device, and biotechnology companies) and cost effectiveness results in cost effectiveness analysis (CEA). DESIGN: Registry based analysis DATA SOURCE: The Tufts Cost-Effectiveness Analysis Registry was used to identify...
Autores principales: | Xie, Feng, Zhou, Ting |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9214880/ https://www.ncbi.nlm.nih.gov/pubmed/35732297 http://dx.doi.org/10.1136/bmj-2021-069573 |
Ejemplares similares
-
Industry sponsorship and publication bias among animal studies evaluating the effects of statins on atherosclerosis and bone outcomes: a meta-analysis
por: Anglemyer, Andrew T, et al.
Publicado: (2015) -
Industry sponsorship bias in research findings: a network meta-analysis of LDL cholesterol reduction in randomised trials of statins
por: Naci, Huseyin, et al.
Publicado: (2014) -
Obesity, the Endocannabinoid System, and Bias Arising from Pharmaceutical Sponsorship
por: McPartland, John M.
Publicado: (2009) -
Sponsorship bias and quality of randomised controlled trials in veterinary medicine
por: Wareham, K. J., et al.
Publicado: (2017) -
Does Industry Sponsorship Undermine the Integrity of Nutrition Research?
por: Katan, Martijn B
Publicado: (2007)